1. Surgical infections: prevention and treatment;Nichols;Am. J. Surg.,1996
2. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infections with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model;Stearne;Antimicrob. Agents Chemother.,2001
3. I.C. Gyssens, L.E.T. Stearne, S.L.C.E. Buijk, J.W. Mouton, I.A.J.M. Bakker-Woudenberg, H.A. Verbrugh, Pharmacodynamics of imipenem with and without drainage in a model of established mixed infection abscess, in: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, the American Society of Microbiology San Diego, CA, 1998, p. 11.
4. I.C. Gyssens, L.E.T. Stearne, J.W. Mouton, W.H. Goessens, H.A. Verbrugh, Efficacy of trovafloxacin in a model of established mixed infection abscesses with B. fragilis and either E. coli or vancomycin-resistant E. faecium, in: 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, the American Society of Microbiology San Francisco, CA, 1999, p. 58.
5. Technetium-99m labelled liposomes to image experimental arthritis;Boerman;Ann. Rheum. Dis.,1997